NYSE LISTED TEST STOCK FOR CTS AND CQS
NYSE LISTED TEST STOCK FOR CTS AND CQS
NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) - Total Liabilities
Latest total liabilities as of June 2021: $3.65 Billion USD
Based on the latest financial reports, NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) has total liabilities worth $3.65 Billion USD as of June 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NYSE LISTED TEST STOCK FOR CTS AND CQS - Total Liabilities Trend (2019–2020)
This chart illustrates how NYSE LISTED TEST STOCK FOR CTS AND CQS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
NYSE LISTED TEST STOCK FOR CTS AND CQS Competitors by Total Liabilities
The table below lists competitors of NYSE LISTED TEST STOCK FOR CTS AND CQS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PRESIDENT STUDIO S.A.
WAR:PRE
|
Poland | zł340.14K |
|
IEMR Resources Inc
V:IRI
|
Canada | CA$43.77K |
|
CAE (CE9.SG)
STU:CE9
|
Germany | €5.66 Billion |
|
Lodzia
TA:LODZ
|
Israel | ILA234.01 Million |
|
SIRIUS XM RADIO - Dusseldorf Stock Exchang
DU:RDO
|
Germany | €16.62 Billion |
Liability Composition Analysis (2019–2020)
This chart breaks down NYSE LISTED TEST STOCK FOR CTS AND CQS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NYSE LISTED TEST STOCK FOR CTS AND CQS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NYSE LISTED TEST STOCK FOR CTS AND CQS (2019–2020)
The table below shows the annual total liabilities of NYSE LISTED TEST STOCK FOR CTS AND CQS from 2019 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | $3.17 Billion | +80.15% |
| 2019-12-31 | $1.76 Billion | -- |